Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here


Masha Kononov, Senior Director Emerging Pharma, USA, and, Gail Frey, Senior Director, Key Accounts, USA, will be attending the AAPS 2020 PharmSci 360 virtual event

For more information and to register please click here